Features
With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the...
With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the time to...
“You don’t need that linear career path – making brave career decisions is actually really valued”.
Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out to the...
We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, Deputy Director...
Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine holds...
Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set to...
Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to the...
Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of HIV...
Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be achieved if...
